364 related articles for article (PubMed ID: 18181228)
1. Maternal characteristics associated with pregnancy exposure to FDA category C, D, and X drugs in a Canadian population.
Yang T; Walker MC; Krewski D; Yang Q; Nimrod C; Garner P; Fraser W; Olatunbosun O; Wen SW
Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):270-7. PubMed ID: 18181228
[TBL] [Abstract][Full Text] [Related]
2. Occurrence and determinants of trimethoprim/sulfamethoxazole use in pregnancy.
Yang T; Walker MC; Krewski D; Yang Q; Garner P; Fraser W; Olatunbosun O; Nimrod C; Wen SW
Acta Obstet Gynecol Scand; 2007; 86(11):1310-6. PubMed ID: 17963058
[TBL] [Abstract][Full Text] [Related]
3. Association between change of health care providers and pregnancy exposure to FDA category C, D and X drugs.
Yang J; Xie R; Krewski D; Wang Y; Walker M; Cao W; Wen SW
Chin Med J (Engl); 2014; 127(4):702-6. PubMed ID: 24534226
[TBL] [Abstract][Full Text] [Related]
4. Patterns of pregnancy exposure to prescription FDA C, D and X drugs in a Canadian population.
Wen SW; Yang T; Krewski D; Yang Q; Nimrod C; Garner P; Fraser W; Olatunbosun O; Walker MC
J Perinatol; 2008 May; 28(5):324-9. PubMed ID: 18288118
[TBL] [Abstract][Full Text] [Related]
5. National patterns of medication use during pregnancy.
Lee E; Maneno MK; Smith L; Weiss SR; Zuckerman IH; Wutoh AK; Xue Z
Pharmacoepidemiol Drug Saf; 2006 Aug; 15(8):537-45. PubMed ID: 16700083
[TBL] [Abstract][Full Text] [Related]
6. Exposure to trimethoprim/sulfamethoxazole but not other FDA category C and D anti-infectives is associated with increased risks of preterm birth and low birth weight.
Yang J; Xie RH; Krewski D; Wang YJ; Walker M; Wen SW
Int J Infect Dis; 2011 May; 15(5):e336-41. PubMed ID: 21345707
[TBL] [Abstract][Full Text] [Related]
7. Physician characteristics and prescription drug use during pregnancy: a population-based study.
Weng SS; Chen YH; Lin CC; Keller JJ; Wang IT; Lin HC
Ann Epidemiol; 2013 Feb; 23(2):54-9. PubMed ID: 23218810
[TBL] [Abstract][Full Text] [Related]
8. Prescription drug use in pregnancy.
Andrade SE; Gurwitz JH; Davis RL; Chan KA; Finkelstein JA; Fortman K; McPhillips H; Raebel MA; Roblin D; Smith DH; Yood MU; Morse AN; Platt R
Am J Obstet Gynecol; 2004 Aug; 191(2):398-407. PubMed ID: 15343213
[TBL] [Abstract][Full Text] [Related]
9. Use of prescription medications with a potential for fetal harm among pregnant women.
Andrade SE; Raebel MA; Morse AN; Davis RL; Chan KA; Finkelstein JA; Fortman KK; McPhillips H; Roblin D; Smith DH; Yood MU; Platt R; H Gurwitz J
Pharmacoepidemiol Drug Saf; 2006 Aug; 15(8):546-54. PubMed ID: 16586470
[TBL] [Abstract][Full Text] [Related]
10. Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001-2006).
Daw JR; Mintzes B; Law MR; Hanley GE; Morgan SG
Clin Ther; 2012 Jan; 34(1):239-249.e2. PubMed ID: 22169049
[TBL] [Abstract][Full Text] [Related]
11. Medication use in early pregnancy-prevalence and determinants of use in a prospective cohort of women.
Cleary BJ; Butt H; Strawbridge JD; Gallagher PJ; Fahey T; Murphy DJ
Pharmacoepidemiol Drug Saf; 2010 Apr; 19(4):408-17. PubMed ID: 20099251
[TBL] [Abstract][Full Text] [Related]
12. Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands.
Bakker MK; Jentink J; Vroom F; Van Den Berg PB; De Walle HE; De Jong-Van Den Berg LT
BJOG; 2006 May; 113(5):559-68. PubMed ID: 16637899
[TBL] [Abstract][Full Text] [Related]
13. Assessment of drug use among pregnant women in Addis Ababa, Ethiopia.
Kebede B; Gedif T; Getachew A
Pharmacoepidemiol Drug Saf; 2009 Jun; 18(6):462-8. PubMed ID: 19334033
[TBL] [Abstract][Full Text] [Related]
14. Maternal tobacco smoking, obesity, and low socioeconomic status during early pregnancy in the etiology of esophageal atresia.
Oddsberg J; Jia C; Nilsson E; Ye W; Lagergren J
J Pediatr Surg; 2008 Oct; 43(10):1791-5. PubMed ID: 18926209
[TBL] [Abstract][Full Text] [Related]
15. Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study.
Nørgaard M; Pedersen L; Gislum M; Erichsen R; Søgaard KK; Schønheyder HC; Sørensen HT
J Antimicrob Chemother; 2008 Jul; 62(1):172-6. PubMed ID: 18400803
[TBL] [Abstract][Full Text] [Related]
16. Drug use by pregnant women and comparable non-pregnant women in The Netherlands with reference to the Australian classification system.
Schirm E; Meijer WM; Tobi H; de Jong-van den Berg LT
Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):182-8. PubMed ID: 15140513
[TBL] [Abstract][Full Text] [Related]
17. FDA pregnancy risk categories and the CPS: do they help or are they a hindrance?
Law R; Bozzo P; Koren G; Einarson A
Can Fam Physician; 2010 Mar; 56(3):239-41. PubMed ID: 20228306
[TBL] [Abstract][Full Text] [Related]
18. Use of antirheumatic drugs in mothers and fathers before and during pregnancy-a population-based cohort study.
Viktil KK; Engeland A; Furu K
Pharmacoepidemiol Drug Saf; 2009 Aug; 18(8):737-42. PubMed ID: 19504626
[TBL] [Abstract][Full Text] [Related]
19. An overview of over the counter drugs in pregnancy and lactation.
Das BP; Joshi M; Pant CR
Kathmandu Univ Med J (KUMJ); 2006; 4(4):545-51. PubMed ID: 18603972
[TBL] [Abstract][Full Text] [Related]
20. Prescribing of sulfasalazine, azathioprine and methotrexate round pregnancy--a descriptive study.
Vroom F; van Roon EN; van den Berg PB; Brouwers JR; de Jong-van den Berg LT
Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):52-61. PubMed ID: 17948319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
